Skip to main content
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: Obesity (Silver Spring). 2021 Apr;29(Suppl 1):S9–S24. doi: 10.1002/oby.23086

TABLE 2.

Phenotypes significantly correlated with weight loss (first 6 mo of intervention) and weight regain (6 mo to 2-4 y depending upon study)

Weight status Weight loss Weight regain
Adiposity (36,37) Baseline r = 0.27, P < 0.001 r = −0.24, P = 0.05
Hunger (38) Changes with weight loss r = 0.35, P = 0.002a
Dietary restraint (39,40)b Initial r = −0.15, P = 0.03
Changes with weight loss r = 0.35, P < 0.01 r = −0.36, P < 0.01
Anxiety/neuroticism (41) Baseline r = 0.50, P < 0.01
Depression and antidepressant use (42) Initial N.S. Increased hazard ratio for weight regain of 1.31 (P = 0.03) for depression and 1.72 (P < 0.005) for antidepressant use
Leptin (adjusted for FM and age)b (43) Initial r = 0.30, P = 0.009 N.S.
Ghrelin (43) Baseline r = 0.31, P = 0.014 N.S.
Leptin/ghrelinc (43,44) Baseline r = −0.33, P = 0.009 Baseline ratio of leptin/ghrelin was associated with an increased risk for weight regain (odds ratio 1.051; P = 0.008)
RMR (36) Baseline N.S. r = −0.38, P = 0.01
ACE (45) Baseline N.S. r = 0.23, P = 0.012
TSHd (46) Baseline r = −0.36, P < 0.001 N.S.
Free T3d (46) Baseline r = −0.33, P = 0.002 N.S.
ΔTSH from baselined (46) Reduced N.S. r = −0.20, P = 0.009
ΔFree T3 from baselined (46) Reduced N.S. r = −0.22, P = 0.003

Data are correlation coefficients of various anatomic, behavioral, biochemical, and physiological phenotypes (independent variables) with weight loss during lifestyle intervention or weight regain once weight loss was completed (dependent variables) except as otherwise indicated. R values are unadjusted unless otherwise noted.

ACE, angiotensin-converting enzyme; FM, fat mass; N.S., not significant; RMR, resting metabolic rate; T3, triiodothyronine; TSH, thyroid-stimulating hormone.

a

Corrected for meeting attendance and self-monitoring in a 6-month outpatient weight-loss program.

b

Dietary restraint prior to weight loss and changes occurring during weight loss have been independently associated with the degree of weight loss and weight regain.

c

Adjusted for fat mass.

d

Pediatric studies adjusted for age, sex, and pubertal stage and correlated with BMI-SDS at baseline after a 1-year intervention or change in BMI-SDS from year 1-2 after the intervention.